ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IQV IQVIA Holdings Inc

227.595
0.425 (0.19%)
Last Updated: 12:04:15
Delayed by 15 minutes

Period:

Draw Mode:

Volume 172,307
Bid Price
Ask Price
News -
Day High 229.8455

Low
167.42

52 Week Range

High
261.73

Day Low 227.31
Company Name Stock Ticker Symbol Market Type
IQVIA Holdings Inc IQV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.425 0.19% 227.595 12:04:15
Open Price Low Price High Price Close Price Prev Close
227.54 227.31 229.8455 227.17
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,114 172,307 $ 227.84 $ 39,258,587 - 167.42 - 261.73
Last Trade Time Type Quantity Stock Price Currency
12:04:15 100 $ 227.595 USD

IQVIA Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
41.37B 181.50M - 14.98B 1.36B 7.48 30.46
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IQVIA News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IQV Message Board. Create One! See More Posts on IQV Message Board See More Message Board Posts

Historical IQV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week236.03236.93222.71230.04753,419-8.44-3.57%
1 Month254.80254.80222.71241.29719,206-27.21-10.68%
3 Months216.25261.73205.38238.63945,27711.355.25%
6 Months189.27261.73167.42219.091,107,79138.3320.25%
1 Year201.11261.73167.42212.831,099,06826.4913.17%
3 Years215.71285.61165.75221.461,016,87911.895.51%
5 Years133.92285.6181.79189.411,110,29893.6869.95%

IQVIA Description

IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Your Recent History

Delayed Upgrade Clock